Renal endothelin system in polycystic kidney disease

Journal of the American Society of Nephrology

Volumn 9, Issue 7, 1998, Pages 1169-1177

  Hocher, Berthold ^a   Zart, Rüdiger ^b   Schwarz, Anja ^b   Vogt, Volker ^b   Braun, Claude ^b   Thöne Reineke, Christa ^b   Braun, Nicole ^b   Neumayer, Hans Hellmut ^b   Koppenhagen, Klaus ^b   Bauer, Christian ^b   Rohmeiss, Peter ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BOSENTAN; ENDOTHELIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; KIDNEY BLOOD FLOW; KIDNEY CYST; KIDNEY EPITHELIUM; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY PARENCHYMA; KIDNEY POLYCYSTIC DISEASE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0031746258     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Grantham JJ: The etiology, pathogenesis, and treatment of autosomal dominant polycystic kidney disease: Recent advances. Am J Kidney Dis 28: 788-803, 1996
2. Bihoreau MT, Ceccherini I, Browne J, Kranzlin B, Romeo G, Lathrop GM, James MR, Gretz N: Location of the first genetic locus, PKDr1, controlling autosomal dominant polycystic kidney disease in Han:SPRD cy/+ rat. Hum Mol Genet 6: 609-613, 1997
3. Schäfer K, Bader M, Gretz N, Oberbäumer I, Bachmann S: Focal overexpression of collagen 4 characterizes the initiation of epithelial changes in polycystic kidney disease. Exp Nephrol 2: 190-195, 1994
4. Hocher B, Thöne-Reineke C, Rohmeiss P, Schmager F, Slowinski T, Burst V, Siegmund F, Quertermous T, Neumayer HH, Bauer C, Schleuning WD, Theuring F: Endothelin-1 transgenic mice develop renal cysts, interstitial fibrosis and glomerulosclerosis but not hypertension. J Clin Invest 99: 1380-1389, 1997
5. Benigni A: Defining the role of endothelins in renal pathophysiology on the basis of selective and unselective endothelin receptor antagonist studies. Curr Opin Nephrol Hypertens 4: 349-353, 1995
6. Benigni A, Zoja C, Remuzzi G: The renal toxicity of sustained glomerular protein traffic. Lab Invest 73: 461-468, 1995
7. Remuzzi G, Benigni A: Progression of proteinuric diabetec and nondiabetic renal disease: A possible role for renal endothelin. Kidney Int Suppl 58: S66-S68, 1997
8. Clozel M, Breu V, Gray GA, Kalna B, Löffler BM, Burri K, Cassal JM, Hirth G, Müller M, Neidhart W, Ramuz H: Pharmacological, characterization of bosentan, a new potent orally active non-peptide endothelin receptor antagonist. J Pharmacol Exp Ther 270: 228-235, 1994
9. Gretz N, Ceccherini I, Kranzlin B, Kloting I, Devoto M, Rohmeiss P, Hocher B, Waldherr R, Romeo G: Gender-dependent disease severity in autosomal polycystic kidney disease of rats. Kidney Int 48: 496-500, 1995
10. Hocher B, Liefeldt L, Thöne-Reineke C, Orzekowski HD, Distler A, Bauer C, Paul M: Characterization of the renal phenotype of transgenic rats expressing the human endothelin-2 gene. Hypertension 28: 196-201, 1996
11. Nambi P, Pullen M, Contino LC: Upregulation of renal endothelin receptors in rats with cyclosporine A-induced nephrotoxicity. Eur J Pharmacol 187: 113-116, 1990
12. Hocher B, Zart R, Diekmann F, Rohmeiss P, Distler A, Neumayer HH, Bauer C, Gross P: Paracrine renal endothelin system in rats with liver cirrhosis. Br J Pharmacol 118: 220-227, 1996
13. Bachmann S, Ramasubbu K: Immunohistochemical colocalization of the alpha-subunit of neutrophil NADPH oxidase and ecto-5′-nucleotidase in kidney and liver. Kidney Int 51: 479-482, 1997
14. Hocher B, Rohmeiss P, Zart R, Diekmann F, Vogt V, Metz D, Fakhury M, Koppenhagen K, Gretz N, Bauer C, Neumayer HH, Distler A: Function and expression of endothelin receptor subtypes in the kidneys of spontaneously hypertensive rats. Cardiovasc Res 31: 499-510, 1996
15. Drost C: Vessel-diameter independent volume flow measurements using ultrasound. Proc San Diego Biomed Symp 17: 299-302, 1978
16. Gretz N, Ecker-Tschirner KH. Kühnle HF, Dahl KV, Kirschfink M. Drescher P, Lasser JJ, Strauch M: Practicability of the inulin plasma single-shot clearance. Contrib Nephrol 81: 220-228, 1990
17. Kühnle HF, Dahl D, Schmidt FH: Fully enzymatic determination in small volume samples without deproteinization. Nephron 62: 104-107, 1992
18. Nakamura T, Ebihara I, Fukui M, Osada S, Tomino Y, Masaki T, Goto K, Furuichi Y, Koide H: Increased endothelin and endothelin receptor mRNA expression in polycystic kidneys of cpk mice. J Am Soc Nephrol 4: 1064-1072, 1993
19. Munemura C, Uemasu J, Kawasaki H: Epidermal growth factor and endothelin in cyst fluid from autosomal dominant polycystic kidney disease cases: Possible evidence of heterogeneity in cystogenesis. Am J Kidney Dis 24: 561-568, 1994
20. Hocher B, Rohmeiss P, Zart R, Diekmann F, Braun C, Koppenhagen K, Bauer C, Distler A, Gretz N: Distribution of endothelin receptor subtypes in the rat kidney: Renal and haemodynamic effects of the mixed ( A/B) endothelin receptor antagonist bosentan. Eur J Clin Chem Clin Biochem 33: 463-472, 1995
21. Ong ACM, Jowett TP, Firth JD, Burton S, Karet FE, Fine LG: An endothelin-1 mediated autocrine growth loop involved in human renal tubular regeneration. Kidney Int 48: 390-401, 1995
22. Clozel M, Löffler BM, Breu V, Hilfiger L, Maire JP, Butscha B: Downregulation of endothelin receptors by autocrine production of endothelin-1. Am J Physiol 265: C188-C192, 1993
23. Arai H, Hori S, Aramori L, Ohkubo H, Nakanishi S: Cloning and expression of a cDNA encoding an endothelin receptor. Nature 348: 730-732, 1990
24. Haendler B, Hechler U, Schleuning WD: Molecular cloning of human endothelin (ET) receptors ETA and ETB. J Cardiovasc Pharmacol 20[Suppl 12]: S1-S4, 1992
25. Hocher B, Thöne-Reineke C, Bauer C, Raschack M, Neumayer HH: The paracrine endothelin system: Pathophysiology and implications in clinical medicine. Eur J Clin Chem Clin Biochem 35: 175-189, 1997